Safety and Efficacy of Intravenous Immune Globulin in Treating Friedreich's Ataxia and Spinocerebellar Ataxia

Sponsor: University of South Florida
Collaborator: Baxter Healthcare Corporation
Information provided by (Responsible Party): Theresa Zesiewicz, University of South Florida
ClinicalTrials.gov Identifier: NCT01350440

This study is currently recruiting participants. (Last Updated on September 9, 2011)